SNDL Stock News: Sundial Growers tumbles and posts a 14% loss for the week
Premium|Take advantage of 50% OFF on your first month.
Start your subscription and get access to all our original articles.
You have reached your limit of 5 free articles for this month.
Get all exclusive analysis, access our analysis and get Gold and signals alerts
Elevate your trading Journey.
UPGRADE- NASDAQ: SNDL fell by 5.24% during Thursday’s trading session.
- Sundial might need another short squeeze to survive.
- Asian countries take new stances on cannabis and CBD products.
NASDAQ: SNDL dipped lower again on Friday and closed the trading week down 14% to hit a new 52-week low price. Shares of SNDL dropped a further 5.24% and closed the trading session at $0.33. Sentiment is extremely risk-off right now and the cannabis industry seems like one of the last ones that investors want to get involved in.
Stay up to speed with hot stocks' news!
The May CPI report was released Friday morning and inflation hit its hottest rate in 40 years. This sent the ten-year treasury bond yield soaring and stocks plummeted for the second straight day. The Dow Jones sank by 880 basis points, while the S&P 500 and the NASDAQ posted 2.91% and 3.52% losses respectively during the session.
At the current rate of Sundial’s decline, the stock might need to see another short squeeze to remain listed on the NASDAQ exchange. The alternative would be a reverse stock split or being delisted to a smaller exchange or even the OTC markets. Sundial does have some bullish catalysts including the potential for its best quarter yet after its acquisition of Alcanna, as well as the outside chance of federal legalization in the US. Still, short squeezes have been few and far between since 2021, so Sundial might need to look to other ways to remain listed.
Sundial stock forecast
Two interesting decisions came down from Asian governments that have been traditionally very strict about drugs like cannabis. First, Thailand became the first Asian country to legalize cannabis for medicinal use although it remains banned for recreational use. Meanwhile in Hong Kong, the government has announced plans to ban CBD products because a study found that a large number of products had traces of THC which is illegal in Hong Kong. It is inconsistency like this that has made it difficult for the cannabis industry to expand to a global scale.
Like this article? Help us with some feedback by answering this survey:
- NASDAQ: SNDL fell by 5.24% during Thursday’s trading session.
- Sundial might need another short squeeze to survive.
- Asian countries take new stances on cannabis and CBD products.
NASDAQ: SNDL dipped lower again on Friday and closed the trading week down 14% to hit a new 52-week low price. Shares of SNDL dropped a further 5.24% and closed the trading session at $0.33. Sentiment is extremely risk-off right now and the cannabis industry seems like one of the last ones that investors want to get involved in.
Stay up to speed with hot stocks' news!
The May CPI report was released Friday morning and inflation hit its hottest rate in 40 years. This sent the ten-year treasury bond yield soaring and stocks plummeted for the second straight day. The Dow Jones sank by 880 basis points, while the S&P 500 and the NASDAQ posted 2.91% and 3.52% losses respectively during the session.
At the current rate of Sundial’s decline, the stock might need to see another short squeeze to remain listed on the NASDAQ exchange. The alternative would be a reverse stock split or being delisted to a smaller exchange or even the OTC markets. Sundial does have some bullish catalysts including the potential for its best quarter yet after its acquisition of Alcanna, as well as the outside chance of federal legalization in the US. Still, short squeezes have been few and far between since 2021, so Sundial might need to look to other ways to remain listed.
Sundial stock forecast
Two interesting decisions came down from Asian governments that have been traditionally very strict about drugs like cannabis. First, Thailand became the first Asian country to legalize cannabis for medicinal use although it remains banned for recreational use. Meanwhile in Hong Kong, the government has announced plans to ban CBD products because a study found that a large number of products had traces of THC which is illegal in Hong Kong. It is inconsistency like this that has made it difficult for the cannabis industry to expand to a global scale.
Like this article? Help us with some feedback by answering this survey:
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.